Wedbush Maintains Outperform on Imax, Raises Price Target to $60

Wedbush analyst Alicia Reese has maintained an Outperform rating on Imax (NYSE: IMAX) and increased the price target from $54 to $60. This adjustment reflects a positive outlook for the company's performance in the market.